{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}],"title":"CD4+CTV-IFN-gamma+,"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}],"title":"CD8+CTV-IFN-gamma+,"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}],"title":"CD8+CD107a+"}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"description":"Positive response per test category. Post-vaccination result higher than pre-vaccination values for each test category criteria. Additional details are reported under Secondary Outcome Measures.","groups":[{"description":"Pneumococcal conjugate vaccine (PCV 13), 0.5ml, 3 to 30 days prior to transplant and then again at 7-10 and 21-24 days after transplant.","id":"OG000","title":"Experimental: PCV 13"}],"paramType":"NUMBER","populationDescription":"All evaluable participants.","reportingStatus":"POSTED","timeFrame":"30 Days Post Vaccine","title":"Number of Participants With Immune Response","type":"PRIMARY","unitOfMeasure":"participants"}